Imidazo-, pyrazolopyrazines and imidazotriazines and their use

US9434731B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Stephan Siegel · Berlin, DE
• Andreas Wilmen
• Susanne Röhrig · Hilden, DE
• Niels Svenstrup · Copenhagen, DK
• Mark Jean Gnoth · Mettmann, DE
• Stefan Heitmeier · Wülfrath, DE
• Ulrich Rester · Wuppertal, DE
• Adrian Tersteegen · Wuppertal, DE
• Michael Gerisch · Wuppertal, DE

Key dates

• Filing date: May 30, 2013
• Grant date: Sep 6, 2016
• Expiry date: Mar 20, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C12N5/0647
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The invention relates to substituted imidazo-, pyrazolopyrazines and imidazotriazines and processes for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of hematological disorders, preferably of leukopenias and neutropenias.